Literature DB >> 18183608

Population-based controlled study of social support, self-perceived stress, activity and work issues, and access to health care in inflammatory bowel disease.

Linda Rogala1, Norine Miller, Lesley A Graff, Patricia Rawsthorne, Ian Clara, John R Walker, Lisa Lix, Jason P Ediger, Cory McPhail, Charles N Bernstein.   

Abstract

BACKGROUND: The Manitoba IBD Cohort Study is a longitudinal, population-based study of multiple determinants of health outcomes in persons with inflammatory bowel disease (IBD) diagnosed within 7 years at enrollment. In this cross-sectional substudy we compared IBD participants' levels of social support, self-perceived stress, disability, and access to healthcare with those of a matched community sample.
METHODS: IBD participants (n = 388) were interviewed using the Canadian Community Health Surveys (CCHS) 1.1 and 1.2 to assess psychosocial variables. The national CCHS data were accessed to extract a community comparison group, matched on age, sex, and geographic residence.
RESULTS: Compared to the community sample, IBD participants received more tangible, affective, or emotional support in the past year and were more likely to have experienced a positive social interaction. Those with IBD were as likely to be employed as those in the community sample, although they reported greater rates of reduced activity and days missed. Work was not identified as a significant source of stress, but physical health was more likely to be identified as a main stressor by those with active IBD compared to the non-IBD sample. Individuals with IBD were twice as likely to report unmet healthcare needs than the community sample; however, there was agreement across both groups regarding common barriers, including long waits and availability.
CONCLUSIONS: While the disease may contribute to greater interference with work quality and daily activities, IBD patients have similar levels of stress and appear to have enhanced social supports relative to those in the community without IBD.

Entities:  

Mesh:

Year:  2008        PMID: 18183608     DOI: 10.1002/ibd.20353

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  15 in total

1.  IGR2096a_1 T and IGR2198a_1 C alleles on IBD5 locus of chromosome 5q31 region confer risk for Crohn's disease in Hungarian patients.

Authors:  Lilla Lakner; Veronika Csöngei; Patrícia Sarlós; Luca Járomi; Eniko Sáfrány; Márta Varga; Péter Orosz; Lili Magyari; Judit Bene; Pál Miheller; Zsolt Tulassay; Béla Melegh
Journal:  Int J Colorectal Dis       Date:  2009-02-13       Impact factor: 2.571

2.  Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis.

Authors:  L Keefer; T H Taft; J L Kiebles; Z Martinovich; T A Barrett; O S Palsson
Journal:  Aliment Pharmacol Ther       Date:  2013-08-19       Impact factor: 8.171

3.  Optimizing management of Crohn's disease within a project management framework: results of a pilot study.

Authors:  Laurie Keefer; Bethany Doerfler; Caroline Artz
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

4.  Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial.

Authors:  Remo Panaccione; Edward V Loftus; David Binion; Kevin McHugh; Shamsul Alam; Naijun Chen; Benoît Guerette; Parvez Mulani; Jingdong Chao
Journal:  Can J Gastroenterol       Date:  2011-08       Impact factor: 3.522

5.  Predictors of health-related quality of life and adherence in Crohn's disease and ulcerative colitis: implications for clinical management.

Authors:  Anilga Tabibian; James H Tabibian; Linda J Beckman; Laura L Raffals; Konstantinos A Papadakis; Sunanda V Kane
Journal:  Dig Dis Sci       Date:  2015-01-06       Impact factor: 3.199

6.  Behavioral interventions may prolong remission in patients with inflammatory bowel disease.

Authors:  Laurie Keefer; Jennifer L Kiebles; Zoran Martinovich; Elyse Cohen; Alyssa Van Denburg; Terrence A Barrett
Journal:  Behav Res Ther       Date:  2010-12-30

7.  Psychosocial factors contributing to inflammatory bowel disease activity and health-related quality of life.

Authors:  Alejandra H Faust; Leslie F Halpern; Sharon Danoff-Burg; Raymond K Cross
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-03

8.  Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy.

Authors:  Zaid Bilgrami; Ameer Abutaleb; Kenechukwu Chudy-Onwugaje; Patricia Langenberg; Miguel Regueiro; David A Schwartz; J Kathleen Tracy; Leyla Ghazi; Seema A Patil; Sandra M Quezada; Katharine M Russman; Charlene C Quinn; Guruprasad Jambaulikar; Dawn B Beaulieu; Sara Horst; Raymond K Cross
Journal:  Dig Dis Sci       Date:  2019-01-02       Impact factor: 3.199

9.  Inflammatory bowel disease: Greek patients' perspective on quality of life, information on the disease, work productivity and family support.

Authors:  Nikos Viazis; Gerasimos Mantzaris; Konstantinos Karmiris; Dimitrios Polymeros; George Kouklakis; Theofanis Maris; John Karagiannis; Dimitrios G Karamanolis
Journal:  Ann Gastroenterol       Date:  2013

10.  Critical Situations in Daily Life as Experienced by Patients With Inflammatory Bowel Disease.

Authors:  Katarina Pihl Lesnovska; Gunilla Hollman Frisman; Henrik Hjortswang; Sussanne Börjeson
Journal:  Gastroenterol Nurs       Date:  2016 May-Jun       Impact factor: 0.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.